220 related articles for article (PubMed ID: 21850490)
1. Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum.
Tunçel N; Korkmaz OT; Tekin N; Şener E; Akyüz F; Inal M
J Mol Neurosci; 2012 Jan; 46(1):51-7. PubMed ID: 21850490
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.
Yelkenli İH; Ulupinar E; Korkmaz OT; Şener E; Kuş G; Filiz Z; Tunçel N
J Mol Neurosci; 2016 Jun; 59(2):280-9. PubMed ID: 27115671
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.
Korkmaz O; Ay H; Ulupinar E; Tunçel N
J Mol Neurosci; 2012 Nov; 48(3):565-73. PubMed ID: 22544516
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.
Korkmaz OT; Tunçel N; Tunçel M; Oncü EM; Sahintürk V; Celik M
J Mol Neurosci; 2010 Jun; 41(2):278-87. PubMed ID: 19953344
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.
Khan MM; Ahmad A; Ishrat T; Khan MB; Hoda MN; Khuwaja G; Raza SS; Khan A; Javed H; Vaibhav K; Islam F
Brain Res; 2010 Apr; 1328():139-51. PubMed ID: 20167206
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats.
Lima LAR; Lopes MJP; Costa RO; Lima FAV; Neves KRT; Calou IBF; Andrade GM; Viana GSB
J Neuroinflammation; 2018 Aug; 15(1):249. PubMed ID: 30170624
[TBL] [Abstract][Full Text] [Related]
9. Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson's disease in rats.
Hegazy MA; Maklad HM; Samy DM; Abdelmonsif DA; El Sabaa BM; Elnozahy FY
Neurochem Int; 2017 Sep; 108():361-371. PubMed ID: 28527632
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease.
Smith MP; Cass WA
Neuroscience; 2007 Feb; 144(3):1057-66. PubMed ID: 17110046
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of the methanolic extract of Hibiscus asper leaves in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Hritcu L; Foyet HS; Stefan M; Mihasan M; Asongalem AE; Kamtchouing P
J Ethnopharmacol; 2011 Sep; 137(1):585-91. PubMed ID: 21704692
[TBL] [Abstract][Full Text] [Related]
12. Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease.
Armentero MT; Levandis G; Bazzini E; Cerri S; Ghezzi C; Blandini F
Neurobiol Dis; 2011 Sep; 43(3):663-8. PubMed ID: 21684338
[TBL] [Abstract][Full Text] [Related]
13. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway.
Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR
Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643
[TBL] [Abstract][Full Text] [Related]
14. The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.
Ciobica A; Olteanu Z; Padurariu M; Hritcu L
J Physiol Biochem; 2012 Mar; 68(1):59-69. PubMed ID: 22006204
[TBL] [Abstract][Full Text] [Related]
15. Behavior and oxidative stress parameters in rats subjected to the animal's models induced by chronic mild stress and 6-hydroxydopamine.
Tuon T; Meirelles SS; de Moura AB; Rosa T; Borba LA; Botelho MEM; Abelaira HM; de Mathia GB; Danielski LG; Fileti ME; Petronilho F; Ignácio ZM; Quevedo J; Réus GZ
Behav Brain Res; 2021 May; 406():113226. PubMed ID: 33684423
[TBL] [Abstract][Full Text] [Related]
16. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
[TBL] [Abstract][Full Text] [Related]
17. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
Ravenscroft P; Chalon S; Brotchie JM; Crossman AR
Exp Neurol; 2004 Jan; 185(1):36-46. PubMed ID: 14697317
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
[TBL] [Abstract][Full Text] [Related]
19. Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease.
Kwon IH; Choi HS; Shin KS; Lee BK; Lee CK; Hwang BY; Lim SC; Lee MK
Neurosci Lett; 2010 Dec; 486(1):29-33. PubMed ID: 20851167
[TBL] [Abstract][Full Text] [Related]
20. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.
Winkler C; Kirik D; Björklund A; Cenci MA
Neurobiol Dis; 2002 Jul; 10(2):165-86. PubMed ID: 12127155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
